DE CENSI LORENZO

Maloberti, A., Colombo, V., Daus, F., De Censi, L., Abrignani, M., Temporelli, P., et al. (2025). Two still unanswered questions about uric acid and cardiovascular prevention: Is a specific uric acid cut-off needed? Is hypouricemic treatment able to reduce cardiovascular risk?. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 35(3(March 2025)) [10.1016/j.numecd.2024.103792]. Detail

Maloberti, A., Valobra, T., Giani, V., Garofani, I., De Censi, L., Galasso, M., et al. (2024). HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY. Intervento presentato a: 33rd European Meeting on Hypertension and Cardiovascular Renal Protection (ESH 2024) - May 31-June 3, 2024, Berlin, Germany [10.1097/01.hjh.0001019700.14760.0e]. Detail

Giani, V., Valobra, T., Capsoni, N., Galasso, M., De Censi, L., Ferretti, C., et al. (2024). Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 124, 61-68 [10.1016/j.ejim.2024.01.029]. Detail

Maloberti, A., Toscani, G., Busti, A., Tognola, C., Intravaia, R., De Censi, L., et al. (2024). EFFECT OF ANTI-PCSK9 ANTIBODIES ON ARTERY STRUCTURE AND FUNCTION: THE NIGUARDA HOSPITAL COHORT. In ESH 2024 Abstract Book (pp.299-299). LIPPINCOTT WILLIAMS & WILKINS [10.1097/01.hjh.0001022608.48617.b6]. Detail

Maloberti, A., Fabbri, S., Colombo, V., Gualini, E., Monticelli, M., Daus, F., et al. (2023). Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(1 (January 2023)) [10.3390/ijms24010170]. Detail